Osang Healthcare Co.,Ltd (036220.KQ)

KRW 11870.0

(-2.63%)

Long Term Debt Summary of Osang Healthcare Co.,Ltd

Osang Healthcare Co.,Ltd's latest annual long term debt in 2023 was 367.49 Million KRW , up 181.48% from previous year.
Osang Healthcare Co.,Ltd's latest quarterly long term debt in 2024 Q2 was - KRW , down 0.0% from previous quarter.
Osang Healthcare Co.,Ltd reported annual long term debt of 130.55 Million KRW in 2022, down -49.59% from previous year.
Osang Healthcare Co.,Ltd reported annual long term debt of 259 Million KRW in 2021, down 0.0% from previous year.
Osang Healthcare Co.,Ltd reported quarterly long term debt of 380.53 Million KRW for 2024 Q1, down 0.0% from previous quarter.
Osang Healthcare Co.,Ltd reported quarterly long term debt of 54.2 Million KRW for 2023 Q2, down -16.57% from previous quarter.

Annual Long Term Debt Chart of Osang Healthcare Co.,Ltd (2023 - 2016)

Historical Annual Long Term Debt of Osang Healthcare Co.,Ltd (2023 - 2016)

Year	Long Term Debt	Long Term Debt Growth
2023	367.49 Million KRW	181.48%
2022	130.55 Million KRW	-49.59%
2021	259 Million KRW	0.0%
2020	- KRW	0.0%
2019	- KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- KRW	0.0%
2024 Q1	380.53 Million KRW	0.0%
2023 Q2	54.2 Million KRW	-16.57%
2023 Q4	367.49 Million KRW	735.51%
2023 Q3	43.98 Million KRW	-18.86%
2023 Q1	64.97 Million KRW	-50.23%
2023 FY	367.49 Million KRW	181.48%
2022 Q4	130.55 Million KRW	-47.92%
2022 Q3	250.69 Million KRW	0.0%
2022 Q2	- KRW	0.0%
2022 Q1	- KRW	0.0%
2021 Q4	- KRW	0.0%
2021 Q3	- KRW	0.0%

Peer Long Term Debt Comparison of Osang Healthcare Co.,Ltd

Name	Long Term Debt	Long Term Debt Difference
InBody Co.,Ltd	3.63 Billion KRW	89.893%
Curexo Inc.	1.48 Billion KRW	75.305%
Seegene, Inc.	1.42 Billion KRW	74.183%
i-SENS, Inc.	45.74 Billion KRW	99.197%
Ray Co., Ltd.	155.4 Million KRW	-136.48%
Gencurix Inc.	5.47 Billion KRW	93.289%
Sugentech Inc.	240 Million KRW	-53.121%
L&C Bio Co., Ltd	541.32 Million KRW	32.112%